Concepts (212)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Aging | 21 | 2022 | 968 | 4.320 |
Why?
|
| Longevity | 8 | 2021 | 134 | 2.670 |
Why?
|
| Superoxide Dismutase-1 | 11 | 2022 | 51 | 2.650 |
Why?
|
| Caloric Restriction | 7 | 2021 | 73 | 2.650 |
Why?
|
| Sirolimus | 5 | 2021 | 76 | 2.520 |
Why?
|
| DNA Methylation | 6 | 2018 | 152 | 1.840 |
Why?
|
| Mice | 35 | 2024 | 4654 | 1.380 |
Why?
|
| Sarcopenia | 6 | 2022 | 42 | 1.380 |
Why?
|
| Animals | 42 | 2024 | 10423 | 1.300 |
Why?
|
| Oxidative Stress | 11 | 2022 | 668 | 1.020 |
Why?
|
| Inflammation | 9 | 2024 | 636 | 0.910 |
Why?
|
| Epigenesis, Genetic | 4 | 2020 | 147 | 0.840 |
Why?
|
| Motor Neurons | 3 | 2022 | 44 | 0.790 |
Why?
|
| Diet Therapy | 1 | 2021 | 9 | 0.750 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2020 | 82 | 0.740 |
Why?
|
| Recombination, Genetic | 1 | 2021 | 62 | 0.730 |
Why?
|
| Blood-Brain Barrier | 1 | 2021 | 83 | 0.690 |
Why?
|
| Genotype | 1 | 2021 | 456 | 0.680 |
Why?
|
| Muscle, Skeletal | 7 | 2022 | 634 | 0.680 |
Why?
|
| Liver | 3 | 2021 | 440 | 0.670 |
Why?
|
| Neuromuscular Junction | 3 | 2021 | 22 | 0.670 |
Why?
|
| Biomedical Research | 1 | 2021 | 97 | 0.650 |
Why?
|
| Gene Expression Regulation | 4 | 2020 | 632 | 0.630 |
Why?
|
| Disease Models, Animal | 7 | 2024 | 1461 | 0.600 |
Why?
|
| Necrosis | 1 | 2018 | 85 | 0.570 |
Why?
|
| Genomics | 1 | 2018 | 123 | 0.540 |
Why?
|
| Frailty | 1 | 2017 | 19 | 0.540 |
Why?
|
| Cellular Senescence | 2 | 2022 | 125 | 0.530 |
Why?
|
| DNA Damage | 2 | 2016 | 151 | 0.530 |
Why?
|
| Interleukin-10 | 1 | 2017 | 72 | 0.520 |
Why?
|
| Interleukin-1beta | 1 | 2016 | 45 | 0.520 |
Why?
|
| Life Expectancy | 1 | 2015 | 23 | 0.500 |
Why?
|
| Mice, Knockout | 8 | 2022 | 848 | 0.490 |
Why?
|
| Interleukin-6 | 1 | 2016 | 193 | 0.470 |
Why?
|
| Apoptosis | 1 | 2018 | 775 | 0.450 |
Why?
|
| Macromolecular Substances | 1 | 2014 | 53 | 0.440 |
Why?
|
| Diet | 1 | 2015 | 232 | 0.430 |
Why?
|
| Hippocampus | 3 | 2019 | 188 | 0.390 |
Why?
|
| Alzheimer Disease | 1 | 2014 | 220 | 0.390 |
Why?
|
| Proteins | 1 | 2014 | 252 | 0.380 |
Why?
|
| Rats | 4 | 2021 | 1576 | 0.370 |
Why?
|
| Mitochondria | 7 | 2022 | 369 | 0.350 |
Why?
|
| Mice, Inbred C57BL | 11 | 2021 | 1576 | 0.320 |
Why?
|
| Models, Animal | 4 | 2018 | 129 | 0.320 |
Why?
|
| Humans | 11 | 2024 | 28099 | 0.310 |
Why?
|
| Gene Expression Profiling | 2 | 2008 | 453 | 0.290 |
Why?
|
| Male | 14 | 2021 | 13492 | 0.290 |
Why?
|
| Neurons | 2 | 2024 | 283 | 0.290 |
Why?
|
| Organ Specificity | 2 | 2018 | 82 | 0.270 |
Why?
|
| Cerebrovascular Circulation | 2 | 2021 | 220 | 0.260 |
Why?
|
| Behavior, Animal | 2 | 2018 | 108 | 0.250 |
Why?
|
| Brain | 3 | 2021 | 741 | 0.250 |
Why?
|
| Superoxide Dismutase | 3 | 2022 | 71 | 0.240 |
Why?
|
| Lactates | 1 | 2024 | 19 | 0.220 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2024 | 68 | 0.200 |
Why?
|
| Neurodegenerative Diseases | 1 | 2022 | 22 | 0.200 |
Why?
|
| Female | 10 | 2021 | 15157 | 0.200 |
Why?
|
| Insulin Resistance | 1 | 2024 | 175 | 0.190 |
Why?
|
| Biology | 1 | 2021 | 14 | 0.190 |
Why?
|
| Litter Size | 1 | 2021 | 12 | 0.190 |
Why?
|
| Mice, Inbred Strains | 1 | 2021 | 61 | 0.190 |
Why?
|
| Multiple Sclerosis | 1 | 2022 | 87 | 0.180 |
Why?
|
| Glucose Tolerance Test | 1 | 2021 | 60 | 0.180 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2021 | 194 | 0.180 |
Why?
|
| Adipose Tissue | 2 | 2024 | 183 | 0.180 |
Why?
|
| Fibrosis | 1 | 2021 | 133 | 0.180 |
Why?
|
| Genetic Techniques | 1 | 2021 | 12 | 0.180 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2022 | 131 | 0.180 |
Why?
|
| DNA | 2 | 2016 | 374 | 0.180 |
Why?
|
| History, 21st Century | 1 | 2021 | 49 | 0.170 |
Why?
|
| Carcinoma, Lewis Lung | 1 | 2020 | 7 | 0.170 |
Why?
|
| Lipid Peroxides | 1 | 2020 | 6 | 0.170 |
Why?
|
| Phospholipases A2 | 1 | 2020 | 9 | 0.170 |
Why?
|
| History, 20th Century | 1 | 2021 | 84 | 0.170 |
Why?
|
| Homeostasis | 1 | 2021 | 118 | 0.170 |
Why?
|
| Liver Neoplasms | 1 | 2022 | 165 | 0.170 |
Why?
|
| Copper | 1 | 2020 | 49 | 0.170 |
Why?
|
| Microglia | 1 | 2020 | 64 | 0.170 |
Why?
|
| Zinc | 1 | 2020 | 63 | 0.160 |
Why?
|
| Astrocytes | 1 | 2020 | 77 | 0.160 |
Why?
|
| Body Composition | 1 | 2021 | 265 | 0.160 |
Why?
|
| Cachexia | 1 | 2020 | 53 | 0.160 |
Why?
|
| Eicosanoids | 1 | 2019 | 10 | 0.160 |
Why?
|
| Transcriptome | 1 | 2020 | 214 | 0.160 |
Why?
|
| Gastrointestinal Microbiome | 1 | 2021 | 123 | 0.150 |
Why?
|
| Cause of Death | 2 | 2015 | 73 | 0.150 |
Why?
|
| Neuronal Plasticity | 1 | 2019 | 50 | 0.150 |
Why?
|
| Excitation Contraction Coupling | 1 | 2018 | 3 | 0.150 |
Why?
|
| Epigenomics | 1 | 2018 | 28 | 0.150 |
Why?
|
| Body Weight | 2 | 2018 | 250 | 0.150 |
Why?
|
| Muscle Weakness | 1 | 2018 | 15 | 0.150 |
Why?
|
| Aging, Premature | 1 | 2018 | 3 | 0.150 |
Why?
|
| Chronic Disease | 2 | 2021 | 271 | 0.150 |
Why?
|
| Oklahoma | 1 | 2021 | 1007 | 0.140 |
Why?
|
| Neuroprotection | 1 | 2018 | 14 | 0.140 |
Why?
|
| Protein Kinases | 3 | 2024 | 152 | 0.140 |
Why?
|
| Enzymes | 1 | 2018 | 23 | 0.140 |
Why?
|
| Circadian Rhythm | 1 | 2018 | 76 | 0.140 |
Why?
|
| Mitochondrial Proteins | 1 | 2018 | 74 | 0.140 |
Why?
|
| Obesity | 2 | 2024 | 669 | 0.140 |
Why?
|
| Motor Activity | 1 | 2018 | 148 | 0.140 |
Why?
|
| Food | 1 | 2017 | 33 | 0.130 |
Why?
|
| Sex Factors | 2 | 2015 | 466 | 0.130 |
Why?
|
| p21-Activated Kinases | 1 | 2016 | 7 | 0.130 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2016 | 16 | 0.130 |
Why?
|
| Muscular Atrophy | 3 | 2022 | 31 | 0.130 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2016 | 26 | 0.130 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2021 | 819 | 0.130 |
Why?
|
| Physical Endurance | 1 | 2017 | 91 | 0.130 |
Why?
|
| 5-Methylcytosine | 1 | 2016 | 3 | 0.130 |
Why?
|
| Sulfites | 1 | 2016 | 8 | 0.130 |
Why?
|
| Quality of Life | 2 | 2022 | 487 | 0.130 |
Why?
|
| Biomarkers | 4 | 2022 | 765 | 0.130 |
Why?
|
| Reactive Oxygen Species | 2 | 2015 | 285 | 0.120 |
Why?
|
| Age Factors | 1 | 2018 | 734 | 0.120 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2008 | 194 | 0.120 |
Why?
|
| Promoter Regions, Genetic | 1 | 2017 | 343 | 0.120 |
Why?
|
| Oxidation-Reduction | 1 | 2016 | 365 | 0.120 |
Why?
|
| Body Mass Index | 1 | 2017 | 399 | 0.120 |
Why?
|
| Muscle Strength | 1 | 2017 | 230 | 0.120 |
Why?
|
| Cognitive Dysfunction | 1 | 2019 | 263 | 0.120 |
Why?
|
| Neurofibrillary Tangles | 1 | 2014 | 12 | 0.120 |
Why?
|
| Plaque, Amyloid | 1 | 2014 | 12 | 0.120 |
Why?
|
| Cognition | 1 | 2018 | 324 | 0.120 |
Why?
|
| Kidney | 1 | 2016 | 286 | 0.120 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2015 | 97 | 0.110 |
Why?
|
| Memory Disorders | 1 | 2014 | 49 | 0.110 |
Why?
|
| Vasodilator Agents | 1 | 2014 | 79 | 0.110 |
Why?
|
| Membrane Proteins | 1 | 2018 | 484 | 0.110 |
Why?
|
| Mice, Transgenic | 1 | 2016 | 507 | 0.110 |
Why?
|
| Autophagy | 1 | 2014 | 73 | 0.110 |
Why?
|
| Phenotype | 3 | 2022 | 681 | 0.100 |
Why?
|
| Signal Transduction | 1 | 2020 | 1435 | 0.100 |
Why?
|
| Cognition Disorders | 1 | 2014 | 184 | 0.100 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2015 | 331 | 0.090 |
Why?
|
| Hydrogen Peroxide | 2 | 2022 | 144 | 0.090 |
Why?
|
| Diquat | 1 | 2008 | 3 | 0.070 |
Why?
|
| RNA, Messenger | 2 | 2008 | 659 | 0.070 |
Why?
|
| Lipid Peroxidation | 1 | 2008 | 47 | 0.070 |
Why?
|
| Glutathione Peroxidase | 1 | 2008 | 26 | 0.070 |
Why?
|
| Reproducibility of Results | 2 | 2008 | 769 | 0.070 |
Why?
|
| Liver Diseases | 1 | 2008 | 52 | 0.070 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2008 | 103 | 0.070 |
Why?
|
| Cell Nucleus | 1 | 2008 | 138 | 0.070 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2008 | 122 | 0.070 |
Why?
|
| Antioxidants | 1 | 2008 | 223 | 0.060 |
Why?
|
| Fructose | 1 | 2024 | 22 | 0.050 |
Why?
|
| Receptor-Interacting Protein Serine-Threonine Kinases | 1 | 2024 | 22 | 0.050 |
Why?
|
| Cell Death | 1 | 2024 | 118 | 0.050 |
Why?
|
| Paralysis | 1 | 2022 | 10 | 0.050 |
Why?
|
| Diet, High-Fat | 1 | 2024 | 137 | 0.050 |
Why?
|
| Dasatinib | 1 | 2022 | 18 | 0.050 |
Why?
|
| Quercetin | 1 | 2022 | 14 | 0.050 |
Why?
|
| Cholesterol | 1 | 2024 | 201 | 0.050 |
Why?
|
| Glucose | 1 | 2024 | 204 | 0.050 |
Why?
|
| Peroxiredoxin III | 1 | 2022 | 4 | 0.050 |
Why?
|
| Cell Line | 1 | 2024 | 696 | 0.050 |
Why?
|
| Weaning | 1 | 2021 | 18 | 0.050 |
Why?
|
| Catalase | 1 | 2021 | 49 | 0.050 |
Why?
|
| Retinal Dehydrogenase | 1 | 2020 | 10 | 0.040 |
Why?
|
| Genetic Markers | 1 | 2020 | 93 | 0.040 |
Why?
|
| Electron Transport Chain Complex Proteins | 1 | 2020 | 12 | 0.040 |
Why?
|
| Mitochondrial Membranes | 1 | 2020 | 20 | 0.040 |
Why?
|
| Cytosol | 1 | 2020 | 47 | 0.040 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 2020 | 50 | 0.040 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2020 | 49 | 0.040 |
Why?
|
| Lipopolysaccharides | 1 | 2020 | 157 | 0.040 |
Why?
|
| Intestinal Mucosa | 1 | 2021 | 197 | 0.040 |
Why?
|
| Intracellular Space | 1 | 2018 | 12 | 0.040 |
Why?
|
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2018 | 18 | 0.040 |
Why?
|
| Reversal Learning | 1 | 2018 | 8 | 0.040 |
Why?
|
| Spatial Memory | 1 | 2018 | 15 | 0.040 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferase 1 | 1 | 2018 | 6 | 0.040 |
Why?
|
| Dioxygenases | 1 | 2018 | 8 | 0.040 |
Why?
|
| Confidence Intervals | 1 | 2018 | 68 | 0.040 |
Why?
|
| Acceleration | 1 | 2018 | 17 | 0.040 |
Why?
|
| Cognitive Aging | 1 | 2018 | 22 | 0.040 |
Why?
|
| Neurogenesis | 1 | 2018 | 22 | 0.040 |
Why?
|
| Cells, Cultured | 1 | 2020 | 985 | 0.040 |
Why?
|
| Calcium Signaling | 1 | 2018 | 72 | 0.040 |
Why?
|
| Memory | 1 | 2018 | 73 | 0.040 |
Why?
|
| Nervous System Diseases | 1 | 2018 | 40 | 0.040 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2018 | 102 | 0.040 |
Why?
|
| In Vitro Techniques | 1 | 2018 | 241 | 0.040 |
Why?
|
| Odds Ratio | 1 | 2018 | 236 | 0.040 |
Why?
|
| Geriatrics | 1 | 2018 | 47 | 0.030 |
Why?
|
| Calcium | 1 | 2018 | 235 | 0.030 |
Why?
|
| Pregnancy | 1 | 2021 | 1191 | 0.030 |
Why?
|
| Sex Characteristics | 1 | 2017 | 172 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2018 | 521 | 0.030 |
Why?
|
| Insulin | 1 | 2018 | 315 | 0.030 |
Why?
|
| Gene Expression | 1 | 2018 | 417 | 0.030 |
Why?
|
| Mortality | 1 | 2015 | 46 | 0.030 |
Why?
|
| F2-Isoprostanes | 1 | 2015 | 2 | 0.030 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 1 | 2015 | 4 | 0.030 |
Why?
|
| Receptors, Cholinergic | 1 | 2015 | 4 | 0.030 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2015 | 29 | 0.030 |
Why?
|
| Reactive Nitrogen Species | 1 | 2015 | 10 | 0.030 |
Why?
|
| Sequence Analysis, DNA | 1 | 2016 | 369 | 0.030 |
Why?
|
| Immunosuppressive Agents | 1 | 2015 | 148 | 0.030 |
Why?
|
| Microscopy, Fluorescence | 1 | 2015 | 163 | 0.030 |
Why?
|
| Cell Cycle Proteins | 1 | 2015 | 187 | 0.030 |
Why?
|
| Nuclear Proteins | 1 | 2015 | 247 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2017 | 2021 | 0.020 |
Why?
|
| Young Adult | 1 | 2017 | 2733 | 0.020 |
Why?
|
| Adolescent | 1 | 2017 | 3122 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2015 | 2379 | 0.020 |
Why?
|
| Aged | 1 | 2017 | 5400 | 0.020 |
Why?
|
| Middle Aged | 1 | 2017 | 7138 | 0.020 |
Why?
|
| Adult | 1 | 2017 | 7740 | 0.010 |
Why?
|
| DNA Probes | 1 | 2004 | 13 | 0.010 |
Why?
|
| Sample Size | 1 | 2004 | 17 | 0.010 |
Why?
|